X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-06 | VAXX | Prime Movers Lab Fund I LP | 10% | S - Sale | $1.74 | -96,936 | 16,657,100 | -1% | -$168,588 | |||||
2023-01-23 | VAXX | Prime Movers Lab Fund I LP | 10% | S - Sale | $3.35 | -500,692 | 16,754,036 | -3% | -$1,678,019 | ||||||
| M | 2022-12-01 | VAXX | Prime Movers Lab Fund I LP | 10% | S - Sale | $2.96 | -348,548 | 17,254,728 | -2% | -$1,030,236 | |||||
2022-09-06 | VAXX | Prime Movers Lab Fund I LP | 10% | S - Sale | $2.40 | -37,358 | 17,603,276 | 0% | -$89,768 | ||||||
| M | 2022-08-23 | VAXX | Prime Movers Lab Fund I LP | 10% | S - Sale | $2.39 | -207,680 | 17,640,634 | -1% | -$496,727 | |||||
| A | 2021-11-18 | VAXX | Diamandis Peter | Dir | S - Sale | $13.00 | -248 | 90,499 | 0% | -$3,224 | |||||
2022-06-16 | VAXX | Reese Lou | Exec COB, 10% | P - Purchase | $1.99 | +100,000 | 65,713,467 | 0% | +$199,290 | ||||||
2022-06-16 | VAXX | Hu Mei Mei | See Remarks, 10% | P - Purchase | $1.99 | +100,000 | 65,713,467 | 0% | +$199,290 | ||||||
2022-06-16 | VAXX | United Biomedical Inc | 10% | P - Purchase | $1.99 | +100,000 | 55,949,839 | 0% | +$199,290 | ||||||
| M | 2022-06-10 | VAXX | Prime Movers Lab Fund I LP | 10% | S - Sale | $2.51 | -179,000 | 17,848,314 | -1% | -$449,869 | |||||
| M | 2022-06-08 | VAXX | United Biomedical Inc | 10% | P - Purchase | $2.83 | +20,978 | 55,849,839 | 0% | +$59,386 | |||||
| M | 2022-06-08 | VAXX | Hu Mei Mei | See Remarks, 10% | P - Purchase | $2.83 | +20,978 | 65,613,467 | 0% | +$59,386 | |||||
| M | 2022-06-08 | VAXX | Reese Lou | Exec COB, 10% | P - Purchase | $2.83 | +20,978 | 65,613,467 | 0% | +$59,386 | |||||
| M | 2022-04-26 | VAXX | United Biomedical Inc | 10% | P - Purchase | $3.48 | +22,912 | 55,828,861 | 0% | +$79,689 | |||||
| M | 2022-04-26 | VAXX | Reese Lou | Exec COB | P - Purchase | $3.48 | +22,912 | 65,592,489 | 0% | +$79,689 | |||||
| M | 2022-04-26 | VAXX | Hu Mei Mei | See Remarks, 10% | P - Purchase | $3.48 | +22,912 | 65,592,489 | 0% | +$79,689 | |||||
2022-04-25 | VAXX | Hu Mei Mei | See Remarks, 10% | P - Purchase | $3.37 | +8,038 | 65,569,577 | 0% | +$27,073 | ||||||
2022-04-25 | VAXX | Reese Lou | Exec COB | P - Purchase | $3.37 | +8,038 | 65,569,577 | 0% | +$27,073 | ||||||
2022-04-25 | VAXX | United Biomedical Inc | 10% | P - Purchase | $3.37 | +8,038 | 9,405,949 | 0% | +$27,073 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |